Organon & Co (OGN)
15.80
-0.37
(-2.29%)
USD |
NYSE |
Nov 26, 16:00
15.80
0.00 (0.00%)
After-Hours: 20:00
Organon Free Cash Flow: 646.00M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 646.00M |
| June 30, 2024 | 787.00M |
| March 31, 2024 | 458.00M |
| December 31, 2023 | 538.00M |
| September 30, 2023 | 424.00M |
| June 30, 2023 | 320.00M |
| March 31, 2023 | 431.00M |
| December 31, 2022 | 431.00M |
| Date | Value |
|---|---|
| September 30, 2022 | 138.00M |
| June 30, 2022 | 343.00M |
| March 31, 2022 | 564.00M |
| December 31, 2021 | 1.97B |
| September 30, 2021 | 2.37B |
| June 30, 2021 | 2.304B |
| March 31, 2021 | 2.772B |
| December 31, 2020 | 1.932B |
Free Cash Flow Range, Past 5 Years
138.00M
Minimum
Sep 2022
2.772B
Maximum
Mar 2021
1.027B
Average
551.00M
Median
Free Cash Flow Benchmarks
| ResMed Inc | 1.347B |
| TG Therapeutics Inc | -28.11M |
| Sage Therapeutics Inc | -320.15M |
| Applied Therapeutics Inc | -81.84M |
| Vor Biopharma Inc | -99.89M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 141.00M |
| Cash from Investing (Quarterly) | -75.00M |
| Cash from Financing (Quarterly) | -78.00M |
| Free Cash Flow Per Share (Quarterly) | 0.2502 |
| Free Cash Flow to Equity (Quarterly) | -28.00M |
| Free Cash Flow to Firm (Quarterly) | 283.52M |
| Free Cash Flow Yield | 15.83% |